Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
341
NCT04176588
A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
Phase: Phase 3
Role: Lead Sponsor
Start: Sep 10, 2019
Completion: Oct 31, 2024